Copyright Reports & Markets. All rights reserved.

Global In Vitro Cytotoxicity Testing Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of In Vitro Cytotoxicity Testing Service by Type
    • 1.3.1 Overview: Global In Vitro Cytotoxicity Testing Service Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global In Vitro Cytotoxicity Testing Service Consumption Value Market Share by Type in 2025
    • 1.3.3 MTT Assay Method
    • 1.3.4 LDH Assay Method
    • 1.3.5 Neutral Red Uptake Assay Method
    • 1.3.6 Others
  • 1.4 Global In Vitro Cytotoxicity Testing Service Market by Application
    • 1.4.1 Overview: Global In Vitro Cytotoxicity Testing Service Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug
    • 1.4.3 Medical Instruments
    • 1.4.4 Cosmetics and Personal Care
    • 1.4.5 Others
  • 1.5 Global In Vitro Cytotoxicity Testing Service Market Size & Forecast
  • 1.6 Global In Vitro Cytotoxicity Testing Service Market Size and Forecast by Region
    • 1.6.1 Global In Vitro Cytotoxicity Testing Service Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global In Vitro Cytotoxicity Testing Service Market Size by Region, (2021-2032)
    • 1.6.3 North America In Vitro Cytotoxicity Testing Service Market Size and Prospect (2021-2032)
    • 1.6.4 Europe In Vitro Cytotoxicity Testing Service Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size and Prospect (2021-2032)
    • 1.6.6 South America In Vitro Cytotoxicity Testing Service Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Eurofins
    • 2.1.1 Eurofins Details
    • 2.1.2 Eurofins Major Business
    • 2.1.3 Eurofins In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.1.4 Eurofins In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Eurofins Recent Developments and Future Plans
  • 2.2 SGS
    • 2.2.1 SGS Details
    • 2.2.2 SGS Major Business
    • 2.2.3 SGS In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.2.4 SGS In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 SGS Recent Developments and Future Plans
  • 2.3 Sartorius
    • 2.3.1 Sartorius Details
    • 2.3.2 Sartorius Major Business
    • 2.3.3 Sartorius In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.3.4 Sartorius In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Sartorius Recent Developments and Future Plans
  • 2.4 UL
    • 2.4.1 UL Details
    • 2.4.2 UL Major Business
    • 2.4.3 UL In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.4.4 UL In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 UL Recent Developments and Future Plans
  • 2.5 Emery Pharma
    • 2.5.1 Emery Pharma Details
    • 2.5.2 Emery Pharma Major Business
    • 2.5.3 Emery Pharma In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.5.4 Emery Pharma In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Emery Pharma Recent Developments and Future Plans
  • 2.6 Nelson Labs
    • 2.6.1 Nelson Labs Details
    • 2.6.2 Nelson Labs Major Business
    • 2.6.3 Nelson Labs In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.6.4 Nelson Labs In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Nelson Labs Recent Developments and Future Plans
  • 2.7 UFAG Laboratorien AG
    • 2.7.1 UFAG Laboratorien AG Details
    • 2.7.2 UFAG Laboratorien AG Major Business
    • 2.7.3 UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.7.4 UFAG Laboratorien AG In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 UFAG Laboratorien AG Recent Developments and Future Plans
  • 2.8 Pacific BioLabs
    • 2.8.1 Pacific BioLabs Details
    • 2.8.2 Pacific BioLabs Major Business
    • 2.8.3 Pacific BioLabs In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.8.4 Pacific BioLabs In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Pacific BioLabs Recent Developments and Future Plans
  • 2.9 NorthEast BioLab
    • 2.9.1 NorthEast BioLab Details
    • 2.9.2 NorthEast BioLab Major Business
    • 2.9.3 NorthEast BioLab In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.9.4 NorthEast BioLab In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 NorthEast BioLab Recent Developments and Future Plans
  • 2.10 Biosafe Ltd
    • 2.10.1 Biosafe Ltd Details
    • 2.10.2 Biosafe Ltd Major Business
    • 2.10.3 Biosafe Ltd In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.10.4 Biosafe Ltd In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Biosafe Ltd Recent Developments and Future Plans
  • 2.11 Creative Bioarray
    • 2.11.1 Creative Bioarray Details
    • 2.11.2 Creative Bioarray Major Business
    • 2.11.3 Creative Bioarray In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.11.4 Creative Bioarray In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Creative Bioarray Recent Developments and Future Plans
  • 2.12 Evercyte
    • 2.12.1 Evercyte Details
    • 2.12.2 Evercyte Major Business
    • 2.12.3 Evercyte In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.12.4 Evercyte In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Evercyte Recent Developments and Future Plans
  • 2.13 IONTOX
    • 2.13.1 IONTOX Details
    • 2.13.2 IONTOX Major Business
    • 2.13.3 IONTOX In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.13.4 IONTOX In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 IONTOX Recent Developments and Future Plans
  • 2.14 Applied StemCell
    • 2.14.1 Applied StemCell Details
    • 2.14.2 Applied StemCell Major Business
    • 2.14.3 Applied StemCell In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.14.4 Applied StemCell In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Applied StemCell Recent Developments and Future Plans
  • 2.15 Xenometrix AG
    • 2.15.1 Xenometrix AG Details
    • 2.15.2 Xenometrix AG Major Business
    • 2.15.3 Xenometrix AG In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.15.4 Xenometrix AG In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Xenometrix AG Recent Developments and Future Plans
  • 2.16 TÜV SÜD
    • 2.16.1 TÜV SÜD Details
    • 2.16.2 TÜV SÜD Major Business
    • 2.16.3 TÜV SÜD In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.16.4 TÜV SÜD In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 TÜV SÜD Recent Developments and Future Plans
  • 2.17 Medicilon
    • 2.17.1 Medicilon Details
    • 2.17.2 Medicilon Major Business
    • 2.17.3 Medicilon In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.17.4 Medicilon In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Medicilon Recent Developments and Future Plans
  • 2.18 Huatongwei
    • 2.18.1 Huatongwei Details
    • 2.18.2 Huatongwei Major Business
    • 2.18.3 Huatongwei In Vitro Cytotoxicity Testing Service Product and Solutions
    • 2.18.4 Huatongwei In Vitro Cytotoxicity Testing Service Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Huatongwei Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global In Vitro Cytotoxicity Testing Service Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of In Vitro Cytotoxicity Testing Service by Company Revenue
    • 3.2.2 Top 3 In Vitro Cytotoxicity Testing Service Players Market Share in 2025
    • 3.2.3 Top 6 In Vitro Cytotoxicity Testing Service Players Market Share in 2025
  • 3.3 In Vitro Cytotoxicity Testing Service Market: Overall Company Footprint Analysis
    • 3.3.1 In Vitro Cytotoxicity Testing Service Market: Region Footprint
    • 3.3.2 In Vitro Cytotoxicity Testing Service Market: Company Product Type Footprint
    • 3.3.3 In Vitro Cytotoxicity Testing Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global In Vitro Cytotoxicity Testing Service Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global In Vitro Cytotoxicity Testing Service Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global In Vitro Cytotoxicity Testing Service Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global In Vitro Cytotoxicity Testing Service Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America In Vitro Cytotoxicity Testing Service Consumption Value by Type (2021-2032)
  • 6.2 North America In Vitro Cytotoxicity Testing Service Market Size by Application (2021-2032)
  • 6.3 North America In Vitro Cytotoxicity Testing Service Market Size by Country
    • 6.3.1 North America In Vitro Cytotoxicity Testing Service Consumption Value by Country (2021-2032)
    • 6.3.2 United States In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 6.3.3 Canada In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe In Vitro Cytotoxicity Testing Service Consumption Value by Type (2021-2032)
  • 7.2 Europe In Vitro Cytotoxicity Testing Service Consumption Value by Application (2021-2032)
  • 7.3 Europe In Vitro Cytotoxicity Testing Service Market Size by Country
    • 7.3.1 Europe In Vitro Cytotoxicity Testing Service Consumption Value by Country (2021-2032)
    • 7.3.2 Germany In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 7.3.3 France In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 7.3.5 Russia In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 7.3.6 Italy In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific In Vitro Cytotoxicity Testing Service Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific In Vitro Cytotoxicity Testing Service Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific In Vitro Cytotoxicity Testing Service Market Size by Region
    • 8.3.1 Asia-Pacific In Vitro Cytotoxicity Testing Service Consumption Value by Region (2021-2032)
    • 8.3.2 China In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 8.3.3 Japan In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 8.3.5 India In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 8.3.7 Australia In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America In Vitro Cytotoxicity Testing Service Consumption Value by Type (2021-2032)
  • 9.2 South America In Vitro Cytotoxicity Testing Service Consumption Value by Application (2021-2032)
  • 9.3 South America In Vitro Cytotoxicity Testing Service Market Size by Country
    • 9.3.1 South America In Vitro Cytotoxicity Testing Service Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa In Vitro Cytotoxicity Testing Service Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa In Vitro Cytotoxicity Testing Service Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa In Vitro Cytotoxicity Testing Service Market Size by Country
    • 10.3.1 Middle East & Africa In Vitro Cytotoxicity Testing Service Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)
    • 10.3.4 UAE In Vitro Cytotoxicity Testing Service Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 In Vitro Cytotoxicity Testing Service Market Drivers
  • 11.2 In Vitro Cytotoxicity Testing Service Market Restraints
  • 11.3 In Vitro Cytotoxicity Testing Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 In Vitro Cytotoxicity Testing Service Industry Chain
  • 12.2 In Vitro Cytotoxicity Testing Service Upstream Analysis
  • 12.3 In Vitro Cytotoxicity Testing Service Midstream Analysis
  • 12.4 In Vitro Cytotoxicity Testing Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global In Vitro Cytotoxicity Testing Service market size was valued at US$ 15290 million in 2025 and is forecast to a readjusted size of US$ 28790 million by 2032 with a CAGR of 9.6% during review period.
    Drivers:
    Rising Demand for Safe and Effective Products: Increased awareness of product safety, especially in pharmaceuticals, cosmetics, and medical devices, fuels demand for rigorous testing services like In Vitro Cytotoxicity Testing.
    Stringent Regulatory Requirements: Global regulatory bodies implement stricter guidelines for product safety, mandating In Vitro Cytotoxicity Testing for various substances before market approval.
    Advancements in Testing Technology: Development of new and more sensitive assays, automated systems, and high-throughput screening platforms enhance test accuracy and efficiency, attracting wider application.
    Outsourcing Trends: Many companies, particularly smaller labs and startups, lack the in-house expertise and resources for cytotoxicity testing, leading to increased outsourcing to specialized service providers.
    Growing Focus on Personalized Medicine: Personalized medicine approaches require cell-based testing to assess individual patient responses to drugs and treatments, boosting demand for specialized cytotoxicity testing services.
    This report is a detailed and comprehensive analysis for global In Vitro Cytotoxicity Testing Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global In Vitro Cytotoxicity Testing Service market size and forecasts, in consumption value ($ Million), 2021-2032
    Global In Vitro Cytotoxicity Testing Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global In Vitro Cytotoxicity Testing Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global In Vitro Cytotoxicity Testing Service market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for In Vitro Cytotoxicity Testing Service
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global In Vitro Cytotoxicity Testing Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eurofins, SGS, Sartorius, UL, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs, NorthEast BioLab, Biosafe Ltd, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    In Vitro Cytotoxicity Testing Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    MTT Assay Method
    LDH Assay Method
    Neutral Red Uptake Assay Method
    Others
    Market segment by Application
    Drug
    Medical Instruments
    Cosmetics and Personal Care
    Others
    Market segment by players, this report covers
    Eurofins
    SGS
    Sartorius
    UL
    Emery Pharma
    Nelson Labs
    UFAG Laboratorien AG
    Pacific BioLabs
    NorthEast BioLab
    Biosafe Ltd
    Creative Bioarray
    Evercyte
    IONTOX
    Applied StemCell
    Xenometrix AG
    TÜV SÜD
    Medicilon
    Huatongwei
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe In Vitro Cytotoxicity Testing Service product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of In Vitro Cytotoxicity Testing Service, with revenue, gross margin, and global market share of In Vitro Cytotoxicity Testing Service from 2021 to 2026.
    Chapter 3, the In Vitro Cytotoxicity Testing Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and In Vitro Cytotoxicity Testing Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of In Vitro Cytotoxicity Testing Service.
    Chapter 13, to describe In Vitro Cytotoxicity Testing Service research findings and conclusion.

    Buy now